Attention Deficit Hyperactivity Disorder

• CLINICAL_TRIALS trial_result · 2010-04-28
  Clinical Trial Update: Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS)

  The COSMOS study, a completed clinical trial sponsored by Johnson & Johnson Taiwan, investigates compliance with ADHD medications to improve…

• CLINICAL_TRIALS trial_result · 2010-04-21
  Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder [Phase 3]

  Phase 3 study evaluating the effectiveness and safety of prolonged-release OROS methylphenidate in adults with ADHD has completed and result…

• CLINICAL_TRIALS trial_result · 2010-04-20
  Clinical Trial Update: A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents [Phase 3]

  Phase 3 clinical trial comparing atomoxetine with standard care in children and adolescents with ADHD to assess long-term functioning; trial…

• CLINICAL_TRIALS trial_result · 2010-04-16
  Clinical Trial Update: A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 1]

  Phase 1 study assessing pharmacokinetics, safety and tolerability after a single dose of JNJ-31001074 in children aged 6-11 with attention-d…

• CLINICAL_TRIALS trial_result · 2010-04-16
  Clinical Trial Update: A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 1]

  A Phase 1 trial evaluating pharmacokinetics, safety and tolerability of a single dose of JNJ-31001074 in pediatric patients aged 12-17 with …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2010-04-09
  Clinical Trial Update: CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD [Phase 3]

  This clinical trial update reports completion of a Phase 3 study evaluating CLONICEL (clonidine sustained-release) as an add-on to stimulant…

• CLINICAL_TRIALS trial_result · 2010-04-06
  Clinical Trial Update: Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD) [Phase 4]

  A Phase 4 trial compared atomoxetine to placebo in children with ADHD and/or reading disorder; results were posted in 2010.

• CLINICAL_TRIALS trial_result · 2010-03-24
  Clinical Trial Update: Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]

  Phase 3 study evaluating the safety and efficacy of CLONICEL for children and adolescents with Attention-Deficit/Hyperactivity Disorder has …

• CLINICAL_TRIALS trial_result · 2010-03-03
  Clinical Trial Update: Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes [Phase 4]

  Phase 4 clinical trial evaluating atomoxetine in young adults with ADHD and its effects on functional outcomes; results were posted in 2010.

• CLINICAL_TRIALS trial_result · 2010-02-26
  Clinical Trial Update: The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder [Phase 2]

  Phase 2 trial assessing the efficacy and safety of a phosphatidylserine-omega-3 supplement in children with attention-deficit/hyperactivity …

• CLINICAL_TRIALS trial_result · 2010-02-23
  Clinical Trial Update: Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]

  Phase 3 trial updates on lisdexamfetamine dimesylate (LDX) for adolescents with ADHD, with results posted after completion.

• CLINICAL_TRIALS trial_result · 2010-02-23
  Clinical Trial Update: Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]

  Open-label, multicentre Phase 3 extension study assessing the safety of prolonged-release OROS methylphenidate in adults with attention defi…

• CLINICAL_TRIALS trial_result · 2010-02-12
  Clinical Trial Update: Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany [Phase 4]

  Phase 4 trial in Germany comparing atomoxetine with placebo in children and adolescents with ADHD and comorbid Oppositional Defiant Disorder…

• CLINICAL_TRIALS trial_result · 2010-02-01
  Clinical Trial Update: Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) [Phase 3]

  Phase 3 trial update on lisdexamfetamine dimesylate in adults with ADHD; study completed with results posted in 2010.

• CLINICAL_TRIALS trial_result · 2010-01-26
  Clinical Trial Update: Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]

  This Phase 3 trial assesses the efficacy and safety of atomoxetine in children with a recent ADHD diagnosis; results have been posted after …

• CLINICAL_TRIALS trial_result · 2010-01-20
  Clinical Trial Update: Transcranial Magnetic Stimulation in Children With Attention Deficit Hyperactivity Disorder (ADHD). A Safety Study [Phase 1]

  This is a Phase 1 safety study evaluating transcranial magnetic stimulation in children with Attention Deficit Hyperactivity Disorder.

• CLINICAL_TRIALS trial_result · 2010-01-18
  Clinical Trial Update: An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD). [Phase 3]

  Phase 3 Italian study evaluating the efficacy of atomoxetine for children and adolescents with attention-deficit/hyperactivity disorder and …

• CLINICAL_TRIALS trial_result · 2010-01-15
  Clinical Trial Update: Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD [Phase 3]

  Phase 3 trial results for the Methylphenidate Transdermal System (MTS) in adolescents with ADHD completed, with safety and efficacy data rep…

• CLINICAL_TRIALS trial_result · 2010-01-13
  Clinical Trial Update: Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA [Phase 3]

  This document provides a Phase 3 clinical trial update focusing on quality assurance for administering methylphenidate to adults with Attent…

• CLINICAL_TRIALS trial_result · 2010-01-06
  Clinical Trial Update: Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]

  A Phase 3 trial evaluating atomoxetine for improving psychosocial functioning in children and adolescents with ADHD has completed and posted…

• CLINICAL_TRIALS trial_result · 2009-12-31
  Clinical Trial Update: A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine [Phase 4]

  A Phase 4 clinical trial evaluated atomoxetine (Strattera) for Attention Deficit Hyperactivity Disorder. Results were posted on 2009-12-31 b…

• CLINICAL_TRIALS trial_result · 2009-12-30
  Clinical Trial Update: The Effect of Methylphenidate on Decision-making Ability of Attention Deficit Hyperactivity Disorder (ADHD) Adults [Phase 1]

  A Phase 1 trial assessing the effect of methylphenidate on decision-making in adults with Attention Deficit Hyperactivity Disorder has been …

• CLINICAL_TRIALS trial_result · 2009-12-23
  Clinical Trial Update: Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]

  Phase 2 trial update for atomoxetine in adults with Attention-Deficit/Hyperactivity Disorder. Results were posted in December 2009.

• CLINICAL_TRIALS trial_result · 2009-12-14
  Clinical Trial Update: Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]

  Phase 3 trial evaluating atomoxetine for Attention Deficit Hyperactivity Disorder in Korean children and adolescents. The study is completed…

• CLINICAL_TRIALS trial_result · 2009-11-26
  Clinical Trial Update: SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms [Phase 3]

  Phase 3 trial update for SPD503 (guanfacine hydrochloride) in ADHD with oppositional symptoms; results posted after completion.